Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2010
08/19/2010US20100210559 Trap-14 as a therapeutic agent
08/19/2010US20100210555 Use of a laminin peptide as a therapeutic agent
08/19/2010US20100210540 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
08/19/2010US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof
08/19/2010US20100210530 Extracellular matrix compositions
08/19/2010US20100210526 Oral administration of a calcitonin
08/19/2010US20100210524 Novel estrogen receptor ligands
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes
08/19/2010US20100209923 Probe for diagnosis of marfan syndrome and a method for screening using the probe
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209474 Malleable implants containing demineralized bone matrix
08/19/2010US20100209470 Demineralized bone matrix devices
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209461 Purified component of blue-green algae and method of use
08/19/2010US20100209456 Treating neoplasms with neurotoxin
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209428 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
08/19/2010US20100209412 Osteogenesis promoter
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010US20100209405 Sericin extracted silkworm fibroin fibers
08/19/2010US20100209403 Adherent cells from adipose or placenta tissues and use thereof in therapy
08/19/2010US20100209400 TAK1-Mediated Regulation of Osteogenesis
08/19/2010US20100209397 Method for non-autologous cartilage regeneration
08/19/2010US20100209390 Cyclosporin analogues
08/19/2010US20100209387 Enhanced medical implant
08/19/2010US20100209341 Treatment of chronic inflammatory conditions
08/19/2010CA2755935A1 Hetero ring derivative
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2218459A1 Sustained release composition containing sdf-1
08/18/2010EP2218337A1 Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217260A2 Amphiphilic peptide matrices for treatment of osteoporosis
08/18/2010EP2217242A1 Methods of use
08/18/2010EP2004696B1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
08/18/2010EP1709049B1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1121115B2 Pufa supplements
08/18/2010EP1036163B1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
08/18/2010CN201551019U Cervical vertebra medicine-placing pillow
08/18/2010CN101809036A Fixed single injection dosage for ocrelizumab (2H7)
08/18/2010CN101808991A Acyclic derivatives as modulators of chemokine receptor activity
08/18/2010CN101808640A Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism
08/18/2010CN101808633A Edible fat composition for enhancing bone strength
08/18/2010CN101805349A Furan-azo- [3,2-g] chromene compound and application thereof
08/18/2010CN101805340A Beta-chain simulative and correlation method thereof
08/18/2010CN101805310A 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-5-thiazolyl formic acid of delta-crystal form, as well as preparation method and medicine composite thereof
08/18/2010CN101805303A Substituted hydroxylamine derivatives with anti-inflammatory activity and preparation method and application thereof
08/18/2010CN101804190A Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof
08/18/2010CN101804180A Traditional Chinese medicine ointment for treating hyperosteogeny and preparation method thereof
08/18/2010CN101804179A Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof
08/18/2010CN101804164A Health-care wine with medlar, flax kernel and fructus cannabis
08/18/2010CN101804160A Medicine line for curing cervical spondylosis and protrusion of lumbar vertebral disc by means of trocar implantation and preparation method thereof
08/18/2010CN101804158A Paste for traumatic injuries
08/18/2010CN101804157A Wound ointment
08/18/2010CN101804146A Traditional Chinese medicine for set of fracture and application thereof
08/18/2010CN101804118A Traditional Chinese medicine powder for preventing and treating talus necrosis
08/18/2010CN101804113A Traditional Chinese medicine preparation for treating cervical syndrome and processing method thereof
08/18/2010CN101804106A Medicine cushion and medicine bag for treating diseases of whole body
08/18/2010CN101804098A Compound cornu cervi degelatinatum preparation as well as preparation method and application thereof
08/18/2010CN101804075A Application of starfishes to preparation of medicament for treating osteoporosis
08/18/2010CN101804040A Ketoprofen slow-release orally disintegrating tablets
08/18/2010CN101601654B Hydrochloric acid Fasudil liposome injection and new application thereof
08/18/2010CN101249173B Traditional Chinese medicine preparation for curing gout and method of preparing the same
08/18/2010CN101244135B Medicine label for treating rheumatism, hyperosteogeny
08/18/2010CN101103994B Medicine for preventing and treating gout and hyperuricemia
08/18/2010CN101024029B Medicine for treating bony arthritis, rheumatism arthritis
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin
08/17/2010US7776361 NELL-1 enhanced bone mineralization
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2585003C An oral preparation having improved bioavailability
08/17/2010CA2527203C Casr antagonist
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals
08/12/2010WO2010090614A1 Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form
08/12/2010WO2010090613A1 The combined pharmaceutical composition in a single dosage form
08/12/2010WO2010089379A1 Method and means for producing tissues and tissues obtained
08/12/2010WO2010088775A1 Methods and uses of hypoxic compartment cells
08/12/2010WO2010036640A3 Compounds for the treatment of inflammatory disorders
08/12/2010US20100204274 Piperidinyl derivatives as modulators of chemokine receptor activity
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204235 Organic compounds
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 820